Antigen presenting cell‐targeted proinsulin expression converts insulin‐specific CD8+ T‐cell priming to tolerance in autoimmune‐prone NOD mice
Type 1 diabetes (T1D) results from autoimmune destruction of insulin‐producing pancreatic β cells. Therapies need to incorporate strategies to overcome the genetic defects that impair induction or maintenance of peripheral T‐cell tolerance and contribute to disease development. We tested whether the...
Saved in:
Published in | European journal of immunology Vol. 47; no. 9; pp. 1550 - 1561 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Wiley Subscription Services, Inc
01.09.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Type 1 diabetes (T1D) results from autoimmune destruction of insulin‐producing pancreatic β cells. Therapies need to incorporate strategies to overcome the genetic defects that impair induction or maintenance of peripheral T‐cell tolerance and contribute to disease development. We tested whether the enforced expression of an islet autoantigen in antigen‐presenting cells (APC) counteracted peripheral T‐cell tolerance defects in autoimmune‐prone NOD mice. We observed that insulin‐specific CD8+ T cells transferred to mice in which proinsulin was transgenically expressed in APCs underwent several rounds of division and the majority were deleted. Residual insulin‐specific CD8+ T cells were rendered unresponsive and this was associated with TCR downregulation, loss of tetramer binding and expression of a range of co‐inhibitory molecules. Notably, accumulation and effector differentiation of insulin‐specific CD8+ T cells in pancreatic lymph nodes was prominent in non‐transgenic recipients but blocked by transgenic proinsulin expression. This shift from T‐cell priming to T‐cell tolerance exemplifies the tolerogenic capacity of autoantigen expression by APC and the capacity to overcome genetic tolerance defects.
Therapies are required to overcome the T‐cell responses that underlie type 1 diabetes. Transgenic expression of proinsulin in antigen‐presenting cells induces tolerance in naïve insulin‐specific CD8+ T cells through mechanisms that TCR downregulation and, potentially, expression of co‐inhibitory molecules. In contrast in non‐Tg mice insulin‐specific CD8+ T cells appeared to undergo effector differentiation in pancreatic lymph nodes. |
---|---|
AbstractList | Type 1 diabetes (T1D) results from autoimmune destruction of insulin‐producing pancreatic β cells. Therapies need to incorporate strategies to overcome the genetic defects that impair induction or maintenance of peripheral T‐cell tolerance and contribute to disease development. We tested whether the enforced expression of an islet autoantigen in antigen‐presenting cells (APC) counteracted peripheral T‐cell tolerance defects in autoimmune‐prone NOD mice. We observed that insulin‐specific CD8+ T cells transferred to mice in which proinsulin was transgenically expressed in APCs underwent several rounds of division and the majority were deleted. Residual insulin‐specific CD8+ T cells were rendered unresponsive and this was associated with TCR downregulation, loss of tetramer binding and expression of a range of co‐inhibitory molecules. Notably, accumulation and effector differentiation of insulin‐specific CD8+ T cells in pancreatic lymph nodes was prominent in non‐transgenic recipients but blocked by transgenic proinsulin expression. This shift from T‐cell priming to T‐cell tolerance exemplifies the tolerogenic capacity of autoantigen expression by APC and the capacity to overcome genetic tolerance defects.
Therapies are required to overcome the T‐cell responses that underlie type 1 diabetes. Transgenic expression of proinsulin in antigen‐presenting cells induces tolerance in naïve insulin‐specific CD8+ T cells through mechanisms that TCR downregulation and, potentially, expression of co‐inhibitory molecules. In contrast in non‐Tg mice insulin‐specific CD8+ T cells appeared to undergo effector differentiation in pancreatic lymph nodes. Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic [beta] cells. Therapies need to incorporate strategies to overcome the genetic defects that impair induction or maintenance of peripheral T-cell tolerance and contribute to disease development. We tested whether the enforced expression of an islet autoantigen in antigen-presenting cells (APC) counteracted peripheral T-cell tolerance defects in autoimmune-prone NOD mice. We observed that insulin-specific CD8+ T cells transferred to mice in which proinsulin was transgenically expressed in APCs underwent several rounds of division and the majority were deleted. Residual insulin-specific CD8+ T cells were rendered unresponsive and this was associated with TCR downregulation, loss of tetramer binding and expression of a range of co-inhibitory molecules. Notably, accumulation and effector differentiation of insulin-specific CD8+ T cells in pancreatic lymph nodes was prominent in non-transgenic recipients but blocked by transgenic proinsulin expression. This shift from T-cell priming to T-cell tolerance exemplifies the tolerogenic capacity of autoantigen expression by APC and the capacity to overcome genetic tolerance defects. Abstract Type 1 diabetes (T1D) results from autoimmune destruction of insulin‐producing pancreatic β cells. Therapies need to incorporate strategies to overcome the genetic defects that impair induction or maintenance of peripheral T‐cell tolerance and contribute to disease development. We tested whether the enforced expression of an islet autoantigen in antigen‐presenting cells (APC) counteracted peripheral T‐cell tolerance defects in autoimmune‐prone NOD mice. We observed that insulin‐specific CD8 + T cells transferred to mice in which proinsulin was transgenically expressed in APCs underwent several rounds of division and the majority were deleted. Residual insulin‐specific CD8 + T cells were rendered unresponsive and this was associated with TCR downregulation, loss of tetramer binding and expression of a range of co‐inhibitory molecules. Notably, accumulation and effector differentiation of insulin‐specific CD8 + T cells in pancreatic lymph nodes was prominent in non‐transgenic recipients but blocked by transgenic proinsulin expression. This shift from T‐cell priming to T‐cell tolerance exemplifies the tolerogenic capacity of autoantigen expression by APC and the capacity to overcome genetic tolerance defects. Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. Therapies need to incorporate strategies to overcome the genetic defects that impair induction or maintenance of peripheral T-cell tolerance and contribute to disease development. We tested whether the enforced expression of an islet autoantigen in antigen-presenting cells (APC) counteracted peripheral T-cell tolerance defects in autoimmune-prone NOD mice. We observed that insulin-specific CD8 T cells transferred to mice in which proinsulin was transgenically expressed in APCs underwent several rounds of division and the majority were deleted. Residual insulin-specific CD8 T cells were rendered unresponsive and this was associated with TCR downregulation, loss of tetramer binding and expression of a range of co-inhibitory molecules. Notably, accumulation and effector differentiation of insulin-specific CD8 T cells in pancreatic lymph nodes was prominent in non-transgenic recipients but blocked by transgenic proinsulin expression. This shift from T-cell priming to T-cell tolerance exemplifies the tolerogenic capacity of autoantigen expression by APC and the capacity to overcome genetic tolerance defects. |
Author | Reeves, Peta L. S. Steptoe, Raymond J. Wong, F. Susan Hamilton‐Williams, Emma E. Rudraraju, Rajeev |
Author_xml | – sequence: 1 givenname: Peta L. S. surname: Reeves fullname: Reeves, Peta L. S. organization: University of Queensland – sequence: 2 givenname: Rajeev surname: Rudraraju fullname: Rudraraju, Rajeev organization: University of Queensland – sequence: 3 givenname: F. Susan surname: Wong fullname: Wong, F. Susan organization: Cardiff University School of Medicine – sequence: 4 givenname: Emma E. surname: Hamilton‐Williams fullname: Hamilton‐Williams, Emma E. organization: University of Queensland – sequence: 5 givenname: Raymond J. orcidid: 0000-0002-6513-6406 surname: Steptoe fullname: Steptoe, Raymond J. email: r.steptoe@uq.edu.au organization: University of Queensland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28665492$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kctO3TAQhi0EKgfaJdvKUjeVUGB8ycVLdLgLwYauI8eeHPkosWmc0LLrI3TVB-yT1NE5sOgCyZJHnm_--a3_gOz64JGQIwYnDICf4tqdcGClLKFSO2TBcs4yySTbJQsAJjOuKtgnBzGuAUAVufpA9nlVFLlUfEH-nPnRrdDTpwEjptqvqMGu-_vr96iHFY5oUys4H6fOeYo_Zy664KkJ_hmHMdJtL03EJzSudYYuz6tj-pheZqk07_pZdwzpdDhobzBNUT2NwfX95DGRaYlHev9wTntn8CPZa3UX8dP2PiTfLi8el9fZ3cPVzfLsLjMSBMuUalEbUJXlXLK2ym3RNmWjTVmK1nJolMRUabANtGXDdcmNbawSlTASLROH5OtGN63_PmEc697F2bT2GKZYM8VyIYUESOiX_9B1mAaf3CVKFByUUrNgtqHMEGIcsK3n3-vhpWZQz4HVKbD6LbDEf96qTk2P9o1-TSgBfAP8cB2-vK9WX9zeiNnFP0ZNqRw |
CitedBy_id | crossref_primary_10_3389_fimmu_2020_582658 crossref_primary_10_1016_j_celrep_2021_108748 crossref_primary_10_1097_MOT_0000000000000565 crossref_primary_10_1111_imcb_12442 |
Cites_doi | 10.1016/S1074-7613(03)00120-1 10.1172/jci.insight.86065 10.2337/diabetes.54.5.1415 10.1016/j.jaut.2003.12.003 10.2337/db09-0694 10.2337/db05-0810 10.4049/jimmunol.178.4.2094 10.1111/j.1365-2249.2008.03810.x 10.1016/j.immuni.2012.09.011 10.1038/ng1958 10.1016/j.clim.2008.08.013 10.1016/j.immuni.2005.01.015 10.1371/journal.pone.0119483 10.1016/j.clim.2008.10.005 10.1038/nature01621 10.2337/db08-0800 10.1016/S0065-2776(08)00804-3 10.4049/jimmunol.1401194 10.2337/db11-0090 10.4049/jimmunol.175.3.1677 10.1371/journal.pone.0085455 10.1155/1995/54219 10.1172/JCI29602 10.4049/jimmunol.177.10.7033 10.1073/pnas.072037299 10.1073/pnas.90.20.9625 10.2337/db09-1801 10.1111/j.1600-6143.2012.04068.x 10.4049/jimmunol.0900428 10.1016/S1074-7613(04)00313-9 10.1172/JCI15995 10.4049/jimmunol.171.8.4040 10.1126/science.1136080 10.1182/blood-2007-07-103200 10.1172/jci.insight.85911 10.4049/jimmunol.1402654 10.2337/db15-1649 10.2337/dc15-0401 10.1002/dmrr.1250 10.1038/nature03523 10.4049/jimmunol.0900032 10.1097/MED.0b013e328355a2d5 10.4049/jimmunol.168.10.5032 10.4049/jimmunol.181.10.7350 10.2337/db15-1498 10.2337/diab.46.1.34 |
ContentType | Journal Article |
Copyright | 2017 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim |
Copyright_xml | – notice: 2017 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim – notice: 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. – notice: 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7T5 7TK 7TM 8FD FR3 H94 K9. M7N P64 RC3 7X8 |
DOI | 10.1002/eji.201747089 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Genetics Abstracts Technology Research Database Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | Genetics Abstracts CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1521-4141 |
EndPage | 1561 |
ExternalDocumentID | 10_1002_eji_201747089 28665492 EJI3991 |
Genre | article Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHMRC funderid: GNT1043315 – fundername: ARC funderid: FT110100372 – fundername: JDRF funderid: 32‐2008‐250; 2‐2013‐34 – fundername: MRC funderid: G0901155 – fundername: Medical Research Council grantid: G0901155 – fundername: NIAID NIH HHS grantid: HHSN272201300006C |
GroupedDBID | --- .3N .55 .GA .GJ .HR .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEFU ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AI. AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOETA ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OHT OIG OK1 OVD P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TEORI UB1 UPT V2E VH1 W8V W99 WBKPD WHWMO WIB WIH WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXSBR X7M XG1 XPP XV2 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7T5 7TK 7TM 8FD FR3 H94 K9. M7N P64 RC3 7X8 |
ID | FETCH-LOGICAL-c4031-99feac098d2241f85d6fb7bac773fd20b94e73fa0db0f7b2a72cdbd9383c4ed13 |
IEDL.DBID | DR2 |
ISSN | 0014-2980 |
IngestDate | Fri Aug 16 10:30:41 EDT 2024 Fri Sep 13 02:28:52 EDT 2024 Fri Aug 23 00:22:27 EDT 2024 Sat Sep 28 08:29:54 EDT 2024 Sat Aug 24 00:51:44 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Autoimmunity APC Tolerance Gene therapy NOD mice CD8+ T cell Insulin |
Language | English |
License | 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4031-99feac098d2241f85d6fb7bac773fd20b94e73fa0db0f7b2a72cdbd9383c4ed13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-6513-6406 |
OpenAccessLink | https://rss.onlinelibrary.wiley.com/doi/am-pdf/10.1002/eji.201747089 |
PMID | 28665492 |
PQID | 1936209991 |
PQPubID | 986365 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_1915343400 proquest_journals_1936209991 crossref_primary_10_1002_eji_201747089 pubmed_primary_28665492 wiley_primary_10_1002_eji_201747089_EJI3991 |
PublicationCentury | 2000 |
PublicationDate | September 2017 2017-09-00 20170901 |
PublicationDateYYYYMMDD | 2017-09-01 |
PublicationDate_xml | – month: 09 year: 2017 text: September 2017 |
PublicationDecade | 2010 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Weinheim |
PublicationTitle | European journal of immunology |
PublicationTitleAlternate | Eur J Immunol |
PublicationYear | 2017 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2007; 39 2004; 21 2004; 22 2010; 59 2015; 38 2005; 175 2011 2006; 55 2011; 60 2005; 435 1997; 46 2015; 10 2002; 99 2008; 129 2003; 171 2012; 19 1993; 90 2003; 18 2010; 184 2009; 130 2014; 193 2006; 116 2008; 100 2012; 12 2005; 22 2003; 111 2006; 177 2015; 195 2008; 181 2007; 178 2009; 58 2016; 1 2007; 315 2013; 38 2002; 168 2016; 65 2005; 54 2009; 183 2003; 423 1996; 4 2014; 9 2011; 27 2008; 111 2008; 154 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 Hosseini H. (e_1_2_7_42_1) 2011 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_48_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1 |
References_xml | – volume: 181 start-page: 7350 year: 2008 end-page: 7355 article-title: The effector T cells of diabetic subjects are resistant to regulation via CD4 FOXP3 regulatory T cells publication-title: J. Immunol. – volume: 4 start-page: 299 year: 1996 end-page: 315 article-title: Tolerance in TCR/cognate antigen double‐transgenic mice mediated by incomplete thymic deletion and peripheral receptor downregulation publication-title: Dev. Immunol. – volume: 100 start-page: 79 year: 2008 end-page: 124 article-title: CD8 T cells in type 1 diabetes publication-title: Adv. Immunol. – volume: 22 start-page: 385 year: 2005 end-page: 396 article-title: Defective central tolerance induction in NOD mice: genomics and genetics publication-title: Immunity – volume: 12 start-page: 2062 year: 2012 end-page: 2071 article-title: Nonmyeloablative conditioning generates autoantigen‐encoding bone marrow that prevents and cures an experimental autoimmune disease publication-title: Am. J. Transplant. – volume: 27 start-page: 773 year: 2011 end-page: 777 article-title: Insulin as a key autoantigen in the development of type 1 diabetes publication-title: Diabetes Metab. Res. Rev. – volume: 154 start-page: 353 year: 2008 end-page: 359 article-title: Increased resistance to CD4 CD25hi regulatory T cell‐mediated suppression in patients with type 1 diabetes publication-title: Clin. Exp. Immunol. – volume: 59 start-page: 1478 year: 2010 end-page: 1486 article-title: Idd9.2 and Idd9.3 protective alleles function in CD4 T‐cells and nonlymphoid cells to prevent expansion of pathogenic islet‐specific CD8 T‐cells publication-title: Diabetes – volume: 1 start-page: e85911 year: 2016 article-title: Incomplete clonal deletion as prerequisite for tissue‐specific minor antigen tolerization publication-title: JCI Insight – volume: 130 start-page: 272 year: 2009 end-page: 279 article-title: APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes publication-title: Clin. Immunol. – volume: 55 start-page: 2098 year: 2006 end-page: 2105 article-title: Deficiency in NOD antigen‐presenting cell function may be responsible for suboptimal CD4 CD25 T‐cell‐mediated regulation and type 1 diabetes development in NOD mice publication-title: Diabetes – volume: 116 start-page: 3258 year: 2006 end-page: 3265 article-title: Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP publication-title: J. Clin. Invest. – volume: 171 start-page: 4040 year: 2003 end-page: 4047 article-title: Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development publication-title: J. I. – volume: 435 start-page: 220 year: 2005 end-page: 223 article-title: Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice publication-title: Nature – volume: 59 start-page: 407 year: 2010 end-page: 415 article-title: Defects in IL‐2R signaling contribute to diminished maintenance of FOXP3 expression in CD4( )CD25( ) regulatory T‐cells of type 1 diabetic subjects publication-title: Diabetes – volume: 99 start-page: 5551 year: 2002 end-page: 5556 article-title: Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H‐2K(d) that stimulates CD8 T cells in insulin‐dependent diabetes mellitus publication-title: Proc. Natl. Acad. Sci. U S A – volume: 315 start-page: 107 year: 2007 end-page: 111 article-title: Differential antigen processing by dendritic cell subsets in vivo publication-title: Science – volume: 111 start-page: 1357 year: 2003 end-page: 1363 article-title: Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes publication-title: JCI – volume: 18 start-page: 713 year: 2003 end-page: 720 article-title: Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8 T cell tolerance publication-title: Immunity – volume: 129 start-page: 413 year: 2008 end-page: 418 article-title: Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood publication-title: Clin. Immunol. – volume: 10 start-page: e0119483 year: 2015 article-title: Blockade of PD‐1/PD‐L1 promotes adoptive T‐cell immunotherapy in a tolerogenic environment publication-title: PLoS One – volume: 1 start-page: e86065 year: 2016 article-title: Perinatal tolerance to proinsulin is sufficient to prevent autoimmune diabetes publication-title: JCI Insight – volume: 54 start-page: 1415 year: 2005 end-page: 1422 article-title: Autoimmune diabetes onset results from qualitative rather than quantitative age‐dependent changes in pathogenic T‐cells publication-title: Diabetes – volume: 178 start-page: 2094 year: 2007 end-page: 2103 article-title: Cognate CD4 help elicited by resting dendritic cells does not impair the induction of peripheral tolerance in CD8 T cells publication-title: J. I. – volume: 183 start-page: 1533 year: 2009 end-page: 1541 article-title: Expression of diabetes‐associated genes by dendritic cells and CD4 T cells drives the loss of tolerance in nonobese diabetic mice publication-title: J. Immunol. – volume: 9 start-page: e85455 year: 2014 article-title: Immunogenic, but not steady‐state, antigen presentation permits regulatory T‐cells to control CD8 T‐cell effector differentiation by IL‐2 modulation publication-title: PLOS One – volume: 60 start-page: 2903 year: 2011 end-page: 2913 article-title: Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes publication-title: Diabetes – volume: 111 start-page: 2091 year: 2008 end-page: 2100 article-title: Steady‐state dendritic cells expressing cognate antigen terminate memory CD8 T‐cell responses publication-title: Blood – volume: 193 start-page: 3409 year: 2014 end-page: 3416 article-title: Contribution of TCR signaling strength to CD8 T cell peripheral tolerance mechanisms publication-title: J. Immunol. – volume: 21 start-page: 817 year: 2004 end-page: 830 article-title: Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim publication-title: Immunity – volume: 168 start-page: 5032 year: 2002 end-page: 5041 article-title: Increased generation of dendritic cells from myeloid progenitors in autoimmune‐prone non‐obese diabetic mice publication-title: J. Immunol. – volume: 90 start-page: 9625 year: 1993 end-page: 9629 article-title: Hematopoietic stem‐cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: Defective regulation of cytokine receptors and protein kinase C publication-title: Proc. Nat. Acad. Sci. USA – volume: 58 start-page: 1156 year: 2009 end-page: 1164 article-title: Activation of insulin‐reactive CD8 T‐cells for development of autoimmune diabetes publication-title: Diabetes – volume: 46 start-page: 34 year: 1997 end-page: 39 article-title: Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice publication-title: Diabetes – volume: 195 start-page: 4841 year: 2015 end-page: 4852 article-title: Ptpn22 and Cd2 Variations Are Associated with Altered Protein Expression and Susceptibility to Type 1 Diabetes in Nonobese Diabetic Mice publication-title: J. Immunol. – volume: 38 start-page: 263 year: 2013 end-page: 274 article-title: T cell‐positive selection uses self‐ligand binding strength to optimize repertoire recognition of foreign antigens publication-title: Immunity – year: 2011 article-title: Non‐myeloablative transplantation of bone marrow expressing self‐antigen establishes peripheral tolerance and completely prevents autoimmunity in mice publication-title: Gene therapy – volume: 184 start-page: 598 year: 2010 end-page: 606 article-title: Targeting antigen to diverse APCs inactivates memory CD8 T cells without eliciting tissue‐destructive effector function publication-title: J. Immunol. – volume: 22 start-page: 131 year: 2004 end-page: 138 article-title: Persistence of recipient lymphocytes in NOD mice after irradiation and bone marrow transplantation publication-title: J. Autoimmun. – volume: 175 start-page: 1677 year: 2005 end-page: 1685 article-title: CD8 T cell tolerance in nonobese diabetic mice is restored by insulin‐dependent diabetes resistance alleles publication-title: J. Immunol. – volume: 19 start-page: 271 year: 2012 end-page: 278 article-title: Revisiting regulatory T cells in type 1 diabetes publication-title: Curr. Opin. Endocrinol. Diabetes Obes. – volume: 423 start-page: 506 year: 2003 end-page: 511 article-title: Association of the T‐cell regulatory gene CTLA4 with susceptibility to autoimmune disease publication-title: Nature – volume: 38 start-page: e55 year: 2015 end-page: 57 article-title: Precipitation of autoimmune diabetes with anti‐PD‐1 immunotherapy publication-title: Diabetes Care – volume: 177 start-page: 7033 year: 2006 end-page: 7041 article-title: Genes within the Idd5 and Idd9/11 diabetes susceptibility loci affect the pathogenic activity of B cells in nonobese diabetic mice publication-title: J. Immunol. – volume: 39 start-page: 329 year: 2007 end-page: 337 article-title: Interleukin‐2 gene variation impairs regulatory T cell function and causes autoimmunity publication-title: Nat. Genet. – volume: 65 start-page: 3429 year: 2016 end-page: 3439 article-title: Peripheral Proinsulin Expression Controls Low Avidity Proinsulin‐Reactive CD8 T‐Cells in Type 1 Diabetes publication-title: Diabetes – volume: 65 start-page: 1679 year: 2016 end-page: 1689 article-title: Proinsulin Expression Shapes the TCR Repertoire but Fails to Control the Development of Low‐Avidity Insulin‐Reactive CD8 T Cells publication-title: Diabetes – ident: e_1_2_7_27_1 doi: 10.1016/S1074-7613(03)00120-1 – year: 2011 ident: e_1_2_7_42_1 article-title: Non‐myeloablative transplantation of bone marrow expressing self‐antigen establishes peripheral tolerance and completely prevents autoimmunity in mice publication-title: Gene therapy contributor: fullname: Hosseini H. – ident: e_1_2_7_38_1 doi: 10.1172/jci.insight.86065 – ident: e_1_2_7_20_1 doi: 10.2337/diabetes.54.5.1415 – ident: e_1_2_7_46_1 doi: 10.1016/j.jaut.2003.12.003 – ident: e_1_2_7_10_1 doi: 10.2337/db09-0694 – ident: e_1_2_7_23_1 doi: 10.2337/db05-0810 – ident: e_1_2_7_25_1 doi: 10.4049/jimmunol.178.4.2094 – ident: e_1_2_7_21_1 doi: 10.1111/j.1365-2249.2008.03810.x – ident: e_1_2_7_32_1 doi: 10.1016/j.immuni.2012.09.011 – ident: e_1_2_7_5_1 doi: 10.1038/ng1958 – ident: e_1_2_7_16_1 doi: 10.1016/j.clim.2008.08.013 – ident: e_1_2_7_12_1 doi: 10.1016/j.immuni.2005.01.015 – ident: e_1_2_7_43_1 doi: 10.1371/journal.pone.0119483 – ident: e_1_2_7_24_1 doi: 10.1016/j.clim.2008.10.005 – ident: e_1_2_7_6_1 doi: 10.1038/nature01621 – ident: e_1_2_7_29_1 doi: 10.2337/db08-0800 – ident: e_1_2_7_4_1 doi: 10.1016/S0065-2776(08)00804-3 – ident: e_1_2_7_33_1 doi: 10.4049/jimmunol.1401194 – ident: e_1_2_7_18_1 doi: 10.2337/db11-0090 – ident: e_1_2_7_7_1 doi: 10.4049/jimmunol.175.3.1677 – ident: e_1_2_7_45_1 doi: 10.1371/journal.pone.0085455 – ident: e_1_2_7_31_1 doi: 10.1155/1995/54219 – ident: e_1_2_7_37_1 doi: 10.1172/JCI29602 – ident: e_1_2_7_15_1 doi: 10.4049/jimmunol.177.10.7033 – ident: e_1_2_7_47_1 doi: 10.1073/pnas.072037299 – ident: e_1_2_7_13_1 doi: 10.1073/pnas.90.20.9625 – ident: e_1_2_7_48_1 doi: 10.2337/db09-1801 – ident: e_1_2_7_40_1 doi: 10.1111/j.1600-6143.2012.04068.x – ident: e_1_2_7_8_1 doi: 10.4049/jimmunol.0900428 – ident: e_1_2_7_11_1 doi: 10.1016/S1074-7613(04)00313-9 – ident: e_1_2_7_36_1 doi: 10.1172/JCI15995 – ident: e_1_2_7_19_1 doi: 10.4049/jimmunol.171.8.4040 – ident: e_1_2_7_28_1 doi: 10.1126/science.1136080 – ident: e_1_2_7_26_1 doi: 10.1182/blood-2007-07-103200 – ident: e_1_2_7_41_1 doi: 10.1172/jci.insight.85911 – ident: e_1_2_7_9_1 doi: 10.4049/jimmunol.1402654 – ident: e_1_2_7_34_1 doi: 10.2337/db15-1649 – ident: e_1_2_7_44_1 doi: 10.2337/dc15-0401 – ident: e_1_2_7_2_1 doi: 10.1002/dmrr.1250 – ident: e_1_2_7_3_1 doi: 10.1038/nature03523 – ident: e_1_2_7_30_1 doi: 10.4049/jimmunol.0900032 – ident: e_1_2_7_17_1 doi: 10.1097/MED.0b013e328355a2d5 – ident: e_1_2_7_14_1 doi: 10.4049/jimmunol.168.10.5032 – ident: e_1_2_7_22_1 doi: 10.4049/jimmunol.181.10.7350 – ident: e_1_2_7_39_1 doi: 10.2337/db15-1498 – ident: e_1_2_7_35_1 doi: 10.2337/diab.46.1.34 |
SSID | ssj0009659 |
Score | 2.3050368 |
Snippet | Type 1 diabetes (T1D) results from autoimmune destruction of insulin‐producing pancreatic β cells. Therapies need to incorporate strategies to overcome the... Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. Therapies need to incorporate strategies to overcome the... Abstract Type 1 diabetes (T1D) results from autoimmune destruction of insulin‐producing pancreatic β cells. Therapies need to incorporate strategies to... Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic [beta] cells. Therapies need to incorporate strategies to overcome... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1550 |
SubjectTerms | Animals Antigen-presenting cells Antigen-Presenting Cells - immunology Antigens APC Autoantigens - immunology Autoimmune diseases Autoimmunity Beta cells CD8 antigen CD8+ T cell CD8-Positive T-Lymphocytes - immunology Cells, Cultured Defects Diabetes mellitus Diabetes Mellitus, Type 1 - immunology Gene therapy Humans Immune Tolerance Immunological tolerance Insulin Islets of Langerhans - immunology Lymph nodes Lymphocyte Activation Lymphocytes Lymphocytes T Male Mice Mice, Inbred NOD NOD mice Pancreas Proinsulin - immunology Rodents T cell receptors Tolerance |
Title | Antigen presenting cell‐targeted proinsulin expression converts insulin‐specific CD8+ T‐cell priming to tolerance in autoimmune‐prone NOD mice |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Feji.201747089 https://www.ncbi.nlm.nih.gov/pubmed/28665492 https://www.proquest.com/docview/1936209991/abstract/ https://search.proquest.com/docview/1915343400 |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS91AEB6K0OKLtrbaWC0rSF8kmsuek-yjeMEKKhQF3-JeJqLVHPHkQNun_oQ-9Qf2lziT3XPktCAUIQ8hu5NNdndmv01mvgFYzwklW2sMT15LGxRbx0a7flw6tEWhbZ106d6OjvsHZ_LwvHce8pxyLIznh5h8cGPN6Ow1K7g2w61H0lC8vmLPLILDSckBfEymx6DoyyN9FJPleUss40yVSeDYJPmtKenpNekfoDmNW7uFZ38eLsaP7P1Nvm6OWrNpf_zF5viMd3oNcwGUim0_i97AC2wW4KVPU_l9AV4dhR_wb-H3dtMyf6e482FLtPAJ_vb_5-cv71OOjooGwcNd4LfgZ9uIzr39vh2KUEYSHOXJnkpiZ7fcEKd0hW9F8pxp7FK0AzpukDN_IEkJPWoHVxzOglSTGmlQHJ_silsyde_gbH_vdOcgDqkdYivJjMRK1WTxE1U6hhB12XP92hRG0_zIa5clRkmkM504k9SFyXSRWWecov20lejSfBFmGmrnPQhMNd1AIhMdytSgyl1iMbW9QlN9qyL4NB7c6s4zeFSeqzmrqL-rSX9HsDIe-ioo8rAifNvPOhQdwdqkmFSQO0Q3OBhxHVo2ZE7WMIIlP2UmLWXMJyhVFsFGN_BPP0K1d_iZEGO6_F-1P8AsX_Oebysw096PcJWgUms-dvrwAEnnE4U |
link.rule.ids | 315,786,790,1382,27957,27958,46329,46753 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB5Rqj4ufdDShkLrSqgXFMjDu4mPiIcWym6lapG4RX5MKmibRZCV2p74CZz4gf0lnYmzC1skpKpSDlH8SmzPzGdn_A3Aakoo2VpjePJaWqDYMjTadcPcoc0ybcuoCffWH3R7h3L_qHN04xS_54eYbrixZDT6mgWcN6Q3rllD8eSYXbMID0e5ugf3SeQ7zaLq8zWBFNPleV0sw0TlUcuySRVszBSftUq3oOYscm1Mz-5T0JOX9h4nX9fHtVm3v_7ic_yfr3oGT1pcKjb9RHoOc1gtwAMfqfLnAjzst__gX8DVZlUzhac49SeXyPYJ3v7_fXHp3crRUdKodXIX-KN1ta1E4-F-Vp-LNo1K8EFPdlYSW9v5mhjSE66KynOwsS-iHtH1DTn4B1Ipocf16JhPtCDlpEYqFINP2-I7abuXcLi7M9zqhW10h9BK0iShUiUp_UjljlFEmXdctzSZ0TRF0tIlkVES6U5HzkRlZhKdJdYZp2hJbSW6OF2E-YraeQ0CY00VSGSuQxkbVKmLLMa2k2nKb1UAHyajW5x6Eo_C0zUnBfV3Me3vAJYnY1-0snxeEMTtJg2QDuD9NJmkkDtEVzgacx6yHDIlhRjAKz9npi0lTCkoVRLAWjPyd79CsbO_R6AxXvqn3O_gUW_YPygO9gYf38BjTveOcMswX5-NcYWQU23eNsLxB3SyF6c |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5Bq1ZcoC2vQEtdCXGp0iaON4mPVberttAFoVbqLfgVVB7ZVZuVgBM_gRM_kF_Smdi71YKEhJByiOJXYs-MPzvjbwCeZ4iSjdGahNfgAsXUsVY2j0vrTFEoUydduLeTYX54Jo7Pe-chzimdhfH8ELMNN9KMzl6Tgo9tvXtDGuo-XJBnFsLhpJS3YVHkGSex7r-94Y8itjxvikXMZZkEkk2sYHeu-Pyk9AfSnAeu3cwzuAfvpu_sHU4-7kxavWO-_Ubn-B8ftQJ3Ayple16MVuGWa9Zgycep_LoGyyfhD_x9-LnXtETgycb-3BLOfIw2_399_-Gdyp3FpFFwcWfuS3C0bVjn337ZXrGQhiXomCe5KrH9frnNTvEJVYXlKdTYe9aO8PrkKPSHw1JMTdrRBZ1ncZgTG2kcG77us89o6x7A2eDgdP8wDrEdYiPQjsRS1mjyE1lawhB12bN5rQutUECy2vJES-HwTiVWJ3WhuSq4sdpKXFAb4WyaPYSFBtt5DMylCisQjpgORaqdzGxiXGp6hcL8RkbwYjq41dhTeFSerJlX2N_VrL8jWJ8OfRU0-apCgJvzDkZHsDVLRh2kDlGNG00oD84bIkNzGMEjLzKzljgRCgrJI9juBv7vr1AdHB8hZEyf_FPuTVh-0x9Ur46GL5_CHUr2XnDrsNBeTtwGwqZWP-tU4xosNRZW |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antigen+presenting+cell-targeted+proinsulin+expression+converts+insulin-specific+CD8+%2B+T-cell+priming+to+tolerance+in+autoimmune-prone+NOD+mice&rft.jtitle=European+journal+of+immunology&rft.au=Reeves%2C+Peta+L+S&rft.au=Rudraraju%2C+Rajeev&rft.au=Wong%2C+F+Susan&rft.au=Hamilton-Williams%2C+Emma+E&rft.date=2017-09-01&rft.eissn=1521-4141&rft.volume=47&rft.issue=9&rft.spage=1550&rft_id=info:doi/10.1002%2Feji.201747089&rft_id=info%3Apmid%2F28665492&rft.externalDocID=28665492 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-2980&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-2980&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-2980&client=summon |